Thursday, September 21, 2017
News
NEWS HOME
»
PRESS RELEASES

Kaneka Eurogentec Announces the Construction of a New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility
  SocialTwist Tell-a-Friend  
   


Date: 13-09-2017 12:25PM
Source: Kaneka Eurogentec
Category: Business/ Finance, Pharmaceutical, General, Science & Research, Healthcare & Biotechnology, Major Diversified Industrial Groups, Manufacturing Companies
Location: Seraing, Belgium

Business Wire India

Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced that its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter. The expansion will allow for the large scale production of biopharmaceuticals including recombinant proteins, antibody fragments and plasmid DNA.

A new facility responding to current market needs

The multi-product facility will include the capability for large scale production using innovative Eurogentec technologies such as the improved production of complex proteins by secretion from yeasts and the production of kilo-scale plasmid DNA for viral and non-viral gene and cell therapies. This expansion will be complementary to the current capabilities and together will provide small and industrial scale production. It will offer on a single site to clients on a worldwide basis biologics manufacturing intended to clinical studies and commercialization.

Lieven Janssens, Executive Vice President at Kaneka Eurogentec stated “The rapid growth in cell and gene therapy products is driving the need for large batches of plasmid DNA; our existing pharma and biotech customers have already expressed the need for kilo-scale manufacturing capabilities and we have developed equipment and methods to respond to these needs with the new facility”.

Ingrid Dheur, Vice President Biologics at Kaneka Eurogentec added “Complex protein structures such as new antibody formats are generating rapid growth in the use of Pichia pastoris for these types of biologics; the new facility will also be equipped for large scale production using such yeast expression systems”.

Construction is expected to start in autumn of 2017. The state-of-the-art facility will be equipped for the production and purification of new biomedicines using cost-effective and safe microbial strains and will include the installation of a 2200 L fermenter, harvest and purification equipment for all expression strategies. Additionally, the expansion will result in the hiring of 40 full time scientific staff trained in the production of GMP therapeutic products.

About Kaneka Eurogentec

Eurogentec was founded in 1985 as a spin-off company of the University of Liège (Belgium). Kaneka Eurogentec contributes to improving health and fighting diseases by supplying products and services to scientists involved in life science research, molecular diagnostics, and therapeutic developments. The Liège-based company is recognised as one of the major suppliers in the field of genomics and proteomics as well as a trusted Contract Development and Manufacturing Organisation (CDMO) for the bio-production of pharmaceuticals (vaccines and medicines

In 2010, Eurogentec, renamed Kaneka Eurogentec in April 2017, became part of Kaneka Corporation, a large Japanese chemical company focusing on technology and innovation.

About Kaneka Corporation

Kaneka is an innovation-oriented chemical company. Traditionally the company has been active in polymers, fermentation, biotechnology and electronics, as well as other fields. Business activities now span a broad spectrum of markets ranging from plastics, EPS resins, chemicals and foodstuffs to pharmaceuticals, medical devices, electrical and electronic materials and synthetic fibers. The life science related activities are currently one of the strategically important domains for Kaneka. The company has been a pioneer among Japanese chemical companies in establishing overseas operations, beginning in 1970 with a subsidiary in Belgium.



CONTACTS :

Kaneka Eurogentec S.A.
Pascal Bolon, Tel: +32 4 366 61 16
Biologics Sales-Marketing Manager
p.bolon@eurogentec.com

More Press Releases

L&T Technology Services Collaborating with Wind River for Intelligent Systems

Visa Announces Team Visa Roster for the Upcoming Olympic and Paralympic Winter Games

Metglas, Inc. and Hitachi Metals, Ltd. File Section 337 Complaint at the International Trade Commission

Colgate-Palmolive (India) Limited, in Partnership with Water For People Launches Water Program in Amravati District, Maharashtra

6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England

Freshworks Launches Freshchat, A Next-gen Customer Messaging Product

Brooks Levitate with DNA AMP Delivers Infinite Energy

iconectiv Emphasizes Need for IoT Interoperability for Reliable Functionality and Security at oneM2M Industry Day in India

This is not a Mobile Phone, it is a Creative Machine

Biosafe Defenses LLC Announces a New Groundbreaking Disinfectant after 10 Years of Research

Andersen Global Expands into Uruguay

Vedica Opens Admissions for the Class of 2019

Ruchi Soya Bags 2 Prestigious Globoil Awards for Business Excellence

North Country Mall Now Rechristened as VR Punjab

OnePlus Unveils Special Offers for a Cracking Diwali Celebration

Grasim Industries - Birla Spunshades gets USDA Biobased Certification

GoDaddy Launches Business Hosting for Fast-growing Small Businesses in India

Gleneagles Global Hospitals Launches #TAKEITTOHEART Campaign on the Occasion of World Heart Day

EB-5 Investor Visa Program being Extended to December 2017

Tata Housing Wins Project of the Year at Project Management Institute (PMI) India Awards 2017

'Amar Ujala Excellence Award 2017' - Celebrating the Exemplary Accomplishments

Ruggedness Within Reach: Olympus’ New L Series Vanta™ Handheld XRF Analyzer

GSMA Announces New Developments in Big Data for Social Good Initiative

A New Era in Fintech Education: SP Jain School of Global Management Launches FinTech Program in Association with Leading FinTech Firm Rubique

 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
INDIA WORLD ASIA
SC to hear Unitech real estate developer...
Sigh of relief for Mumbaikars, as rains ...
Biggest challenge India facing today is ...
Rahul attacks Centre over intolerance, s...
Rohingya Muslims can be misled, exploite...
Bengal Commission for Child Rights files...
More...    
 
 Top Stories
Key Indian equity market indices op... 
Google acquires HTC's Pixel team fo... 
Divisive politics ruining India's r... 
MSE launches Member Activation Driv... 
Biggest challenge India facing toda... 
Sushma Swaraj meets Chinese Foreign... 
HTC to get USD 1.1 Billion from Goo... 
Growing concern in US over threats ...